| Literature DB >> 32992895 |
Elisa Regalbuto1,2, Anna Anselmo1, Stefania De Sanctis1, Valeria Franchini1, Florigio Lista1, Monica Benvenuto3,4, Roberto Bei4, Laura Masuelli5, Guglielmo D'Inzeo6, Alessandra Paffi6, Eugenio Trodella6, Antonella Sgura2.
Abstract
The increasing exposure to radiofrequency electromagnetic fields (RF-EMF), especially from wireless communication devices, raises questions about their possible adverse health effects. So far, several in vitro studies evaluating RF-EMF genotoxic and cytotoxic non-thermal effects have reported contradictory results that could be mainly due to inadequate experimental design and lack of well-characterized exposure systems and conditions. Moreover, a topic poorly investigated is related to signal modulation induced by electromagnetic fields. The aim of this study was to perform an analysis of the potential non-thermal biological effects induced by 2.45 GHz exposures through a characterized exposure system and a multimethodological approach. Human fibroblasts were exposed to continuous (CW) and pulsed (PW) signals for 2 h in a wire patch cell-based exposure system at the specific absorption rate (SAR) of 0.7 W/kg. The evaluation of the potential biological effects was carried out through a multimethodological approach, including classical biological markers (genotoxic, cell cycle, and ultrastructural) and the evaluation of gene expression profile through the powerful high-throughput next generation sequencing (NGS) RNA sequencing (RNA-seq) approach. Our results suggest that 2.45 GHz radiofrequency fields did not induce significant biological effects at a cellular or molecular level for the evaluated exposure parameters and conditions.Entities:
Keywords: 2.45 GHz; RNA sequencing (RNA-seq); RT-PCR; Wi-Fi; gene expression; genotoxic effect
Mesh:
Year: 2020 PMID: 32992895 PMCID: PMC7584027 DOI: 10.3390/ijms21197069
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Cell cycle analysis on HDF cells exposed to 2.45 GHz CW and PW. No differences were observed 2 and 24 h after irradiation with both continuous wave (CW) and pulsed wave (PW) signals. Results are representative of three experiments. Results obtained with the cells exposed to CW or PW signals were compared to those obtained with the corresponding sham cells (exposed 2 h vs. sham 2 h; exposed 24 h vs. sham 24 h; 2-tailed t-test). Not significant (NS).
| 2.45 GHz | Time Point | Sample | Sub-G1 1 | G0/G1 | S | G2/M | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mean |
| Mean |
| Mean |
| Mean |
| |||
| CW | 2 h | Sham | 1.92 ± 0.42 | 50.92 ± 12.97 | 6.85 ± 1.77 | 40.61 ± 11.66 | ||||
| Exposed | 1.44 ± 0.76 | NS | 50.12 ± 12.95 | NS | 7.97 ± 2.18 | NS | 40.81 ± 10.13 | NS | ||
| 24 h | Sham | 0.80 ± 0.66 | 86.03 ± 2.33 | 3.46 ± 0.49 | 9.85 ± 2.35 | |||||
| Exposed | 0.82 ± 0.70 | NS | 86.31 ± 2.61 | NS | 3.53 ± 0.59 | NS | 9.50 ± 2.81 | NS | ||
| PW | 2 h | Sham | 0.71 ± 0.13 | 72.84 ± 1.12 | 4.06 ± 0.61 | 22.62 ± 1.58 | ||||
| Exposed | 0.84 ± 0.13 | NS | 75.00 ± 0.97 | NS | 4.17 ± 0.51 | NS | 20.23 ± 1.43 | NS | ||
| 24 h | Sham | 0.49 ± 0.16 | 84.10 ± 0.54 | 2.00 ± 0.17 | 13.53 ± 0.41 | |||||
| Exposed | 0.44 ± 0.18 | NS | 82.43 ± 1.47 | NS | 2.24 ± 0.34 | NS | 15.03 ± 1.02 | NS | ||
1 Percentage of cells in the sub-G1, G0/G1, S and G2/M phase were calculated using Cell Quest software.
Figure 1H2AX histone/p53 binding protein 1 (γ-H2AX/53BP1) foci analysis on HDF exposed to 2.45 GHz. No significant differences were observed 30 min, 2 h, or 24 h after exposure to 2.45 GHz CW (a) and PW (b), with respect to sham samples. Results obtained with the cells exposed to CW or PW signals were compared to those obtained with the corresponding sham cells (exposed 30 min vs. sham 30 min; exposed 2 h vs. sham 2 h; exposed 24 h vs. sham 24 h; 2-tailed t-test). Data are representative of four experiments, and bars denote the standard error.
Figure 2CREST analysis on HDF exposed to 2.45 GHz. No significant increase in MN tot or in the frequency of MN+ and MN− in 2.45 GHz CW (a) and PW (b) exposed, with respect to sham samples were observed. Data are representative of four experiments, and bars denote the standard error.
Figure 3Ultrastructural analysis of HDF cells exposed to 2.45 GHz. (Panel A): sham (a,c) and 2.45 GHz CW- (b,d) exposed HDF. Exposed cells were examined 2 h (b) and 24 h (d) after exposure. Nucleus (N), rough endoplasmic reticulum (rer), lysosome (ly), mitochondria (m) (bars correspond to 1 µm). No morphological differences were found between sham or exposed cells. (Panel B): sham (a,c) and 2.45 GHz PW- (b,d) exposed HDF. Exposed cells were examined 2 h (b) and 24 h (d) after exposure. (Bars correspond to 1 µm). No morphological differences were found between sham and exposed cells.
List of genes differentially expressed between exposed and sham samples after exposure to 2.45 GHz CW. The table includes gene name, gene function, fold change (FC), and regulation.
| 2.45 GHz CW | Gene ID | Gene Name | Description | FC | Regulation |
|---|---|---|---|---|---|
| 0 min after exposure | ACOT4 | Acyl-coenzyme A thioesterase 4 | Signaling receptor binding and palmitoyl-CoA hydrolase activity | 1.6 | up |
| DLX5 | Homeobox protein DLX-5 | Transcriptional factor involved in bone development | 2 | up | |
| FAM72D | Protein FAM72D | Unknown function | 2 | up | |
| LRP2BP | LRP2-binding protein | Protein binding | 2.5 | down | |
| NIPSNAP3B | Protein NipSnap homolog 3B | Rutative roles in vesicular trafficking | 2.2 | up | |
| SUN3 | SUN domain-containing protein 3 | Protein binding | 2.3 | up | |
| 2 h after exposure | HES4 | Transcription factor HES-4 | Basic helix-loop-helix transcription factor | 1.6 | down |
| HMCN1 | Hemicentin-1 | Receptor binding | 1.8 | up | |
| ALMS1 | Alstrom syndrome protein 1 | Cytoskeletal protein binding | 1.5 | up | |
| ANKRD36C | Ankyrin repeat domain-containing protein 36 | Protein Coding gene involved in ion channel inhibitor activity | 1.6 | down | |
| GRIP2 | Glutamate receptor-interacting protein 2 | Multi-PDZ domain scaffolding proteins required for dendrite development | 1.5 | down | |
| BSN | Protein bassoon | Scaffolding protein involved in organizing the presynaptic cytoskeleton | 1.6 | up | |
| FAM53A | Protein FAM53A | Encodes a secreted peptide hormone and member of the EGF family of proteins | 1.5 | down | |
| EREG | Epiregulina | Transient receptor potential cation channel | 1.5 | down | |
| SLC9B1 | Sodium/hydrogen exchanger 9B1 | Transmembrane transporter activity | 1.7 | down | |
| LUCAT1 | lung cancer associated transcript 1 | Non-coding RNA | 1.6 | down | |
| EGR1 | Early growth response protein 1 | Transcriptional regulator | 1.7 | up | |
| AC005618.6 | Protocadherin gamma-B3 | Cell adhesion, cell-cell signaling | 1.8 | up | |
| HIST1H2AD | Histone H2A type 1-D | Histone | 2 | down | |
| HIST1H2BG | Histone H2B type 1-C/E/F/G/I | Histone | 1.8 | down | |
| IER3 | Radiation-inducible immediate-early gene IEX-1 | Cell proliferation and survival | 2.2 | down | |
| PRSS35 | Inactive serine protease 35 | Serin protease activity | 1.7 | down | |
| SAMD3 | Sterile alpha motif domain-containing protein 3 | Protein binding | 1.8 | up | |
| GPER1 | G-protein coupled estrogen receptor 1 | Protein binding | 1.5 | down | |
| RIMS2 | Regulating synaptic membrane exocytosis protein 2 | Protein binding | 1.6 | up | |
| ZNF462 | Zinc finger protein 462 | Protein binding | 1.7 | up | |
| SYNPO2L | Synaptopodin 2-like protein | Protein binding | 1.8 | up | |
| CNNM1 | Metal transporter CNNM1 | Protein binding | 1.5 | down | |
| C11orf96 | Uncharacterized protein C11orf96 | 1.7 | down | ||
| BEST1 | Bestrophin-1 | Ion binding | 1.6 | up | |
| STYK1 | Tyrosine-protein kinase STYK1 | Receptor binding | 1.5 | up | |
| RPPH1 | Ribonuclease P RNA Component H1 | long non-coding RNA | 3.9 | down | |
| RN7SL1 | RNA, 7SL, cytoplasmic 1 | small cytoplasmic RNA | 2.7 | down | |
| RN7SL2 | RN7SL2 | small cytoplasmic RNA | 4.1 | down | |
| RHOJ | Rho-related GTP-binding protein RhoJ | small GTPase | 1.5 | down | |
| SYNE2 | Nesprin-2 | Actin binding | 2 | up | |
| AHNAK2 | Protein AHNAK2 | RNA binding | 1.5 | up | |
| FBXL22 | F-box and leucine-rich protein 22 | Protein ubiquitination | 1.6 | up | |
| SLC43A2 | Large neutral amino acids transporter small subunit 4 | Transmembrane transporter activity | 1.7 | up | |
| MYCBPAP | MYCBP-associated protein | Cell differenziation | 2 | up | |
| ZNF433 | Zinc finger protein 433 | DNA-binding (transcription) | 1.3 | up | |
| ZNF233 | Zinc finger protein 233 | Nucleic acid binding, regulation of transcription | 1.8 | up | |
| RP1-198K11.5 | Non-coding RNA | 1.5 | down | ||
| MXRA5 | Matrix-remodeling-associated protein 5 | Receptor binding | 1.8 | up | |
| RMRP | RNA Component Of Mitochondrial RNA Processing Endoribonuclease | Non-coding RNA | 8.8 | down | |
| 24 h after exposure | ANKRD36C | Ankyrin repeat domain-containing protein 36 | Protein Coding gene, ion channel inhibitor activity | 1.6 | down |
| MIR145 | microRNA 145 | Non-coding RNA | 1.4 | up | |
| KIAA0895 | Uncharacterized protein KIAA0895 | 1.8 | up | ||
| LCNL1 | Lipocalin-like 1 protein | Binding, isomerase activity | 2.3 | up | |
| RASGEF1A | Ras-GEF domain-containing family member 1A | protein binding, small GTPase regulator activity | 1.5 | up | |
| RN7SL1 | RNA, 7SL, cytoplasmic 1 | small cytoplasmic RNA | 1.8 | down | |
| RN7SL2 | RNA, 7SL, cytoplasmic 2 | small cytoplasmic RNA | 1.8 | down | |
| RGS11 | Regulator of G-protein signaling 11 | Regulator of G protein signaling | 1.7 | up |
List of genes differentially expressed between exposed and sham samples after exposure to 2.45 GHz PW. The table includes gene name, gene function, fold change (FC), and regulation.
| 2.45 GHz PW | Gene ID | Gene Name | Description | FC | Regulation |
|---|---|---|---|---|---|
| 0 min after exposure | KIAA1324 | UPF0577 protein KIAA1324 | RNA binding | 1.6 | up |
| KIAA1211 | Uncharacterized protein KIAA1211 | Unknown function | 2.3 | up | |
| CXCL3 | C-X-C motif chemokine 3 | Chemokine | 1.6 | down | |
| EGR3 | Early growth response protein 3 | Transcriptional regulator | 1.5 | down | |
| SLC16A13 | Monocarboxylate transporter 13 | Transmembrane transporter | 1.5 | up | |
| 2 h after exposure | TMEM240 | Transmembrane protein 240 | Transmembrane-domain containing protein | 1.54 | up |
| TNFRSF25 | Tumor necrosis factor receptor superfamily member 25 | Signaling receptor activity | 1.7 | up | |
| BEST4 | Bestrophin-4 | Anion channel | 1.8 | up | |
| RNF175 | RING finger protein 175 | Ubiquitin- protein ligase | 1.7 | up | |
| KLKB1 | Plasma kallikrein | Serin-protease | 1.5 | down | |
| PTGER4 | Prostaglandin E2 receptor EP4 subtype | G-protein coupled receptor | 2 | down | |
| MDFI | MyoD family inhibitor | Transcription factor binding | 2 | up | |
| PPP1R9A | Neurabin-1 | Actin binding | 1.9 | down | |
| RMRP | RNA Component Of Mitochondrial RNA Processing Endoribonuclease | Non-coding RNA | 5.7 | down | |
| PRUNE2 | Protein prune homolog 2 | Pyrophosphatase activity | 1.6 | down | |
| ENO4 | Enolase 4 | Lyase activity | 1.9 | down | |
| KCNQ1OT1 | KCNQ1 opposite strand/antisense transcript 1 | non-coding RNA | 1.7 | down | |
| OLR1 | Oxidized low-density lipoprotein receptor 1 | Lipoprotein receptor | 2.1 | down | |
| HOXC11 | Homeobox protein Hox-C11 | Transcription factor | 1.7 | up | |
| PTPRQ | Receptor-type tyrosine-protein phosphatase R | Protein phosphatase | 1.8 | down | |
| PAPLN | Papilin | Peptidase activity | 1.7 | down | |
| TMEM121 | Transmembrane protein 121 | 2 | up | ||
| ATF7IP2 | Activating transcription factor 7-interacting protein 2 | ATPase activity | 2.4 | down | |
| CNBD2 | Cyclic nucleotide-binding domain-containing protein 2 | cAMP binding | 1.7 | up | |
| AHNAK2 | Protein AHNAK2 | RNA binding | 1.8 | down | |
| LIF | Leukemia inhibitory factor | Cytokine activity | 1.8 | down | |
| PDZD4 | PDZ domain-containing protein 4 | Ubiquitin protein ligase activity | 2.1 | up | |
| 24 h after exposure | PPP1R1C | Protein phosphatase 1 regulatory subunit 1C | Signaling molecule, phosphatase inhibitor | 2.6 | up |
| ADAMTS13 | A disintegrin and metalloproteinase with thrombospondin motifs 13 | Metallopeptidase activity | 1.5 | up | |
| PANO | Proapoptotic Nucleolar Protein 1 | Apoptosis-inducing protein | 1.9 | up | |
| NEAT1 | nuclear paraspeckle assembly transcript 1 | Non-coding RNA | 1.5 | up | |
| VAMP1 | Vesicle-associated membrane protein 1 | Transport | 1.5 | up | |
| GOLGA8B | Golgin subfamily A member 8B | Membrane traffic protein | 1.5 | up | |
| GUSBP11 | Putative inactive beta-glucuronidase protein GUSBP11 | Hydrolase activity | 1.5 | up |
Figure 4Percentage of differential gene expressions (DGEs) involved in the different biological processes and molecular functions, as reported in gene ontology (GO) term analysis, for both types of signals evaluated. (a) Percentage of genes involved in each biological process after exposure to 2.45 GHz CW. (b) Percentage of genes involved in each molecular function after exposure to 2.45 GHz CW. (c) Percentage of genes involved in each biological process after exposure to 2.45 GHz PW. (d) Percentage of genes involved in each molecular function after exposure to 2.45 GHz PW.
Figure 5GO functional networks for down-regulated and up-regulated genes for 2.45 CW exposed samples (a) and 2.45 PW exposed samples (b). The down- and up-regulated genes are shown in red and blue, respectively.
In the table, the results obtained from the RT-PCR validation on the selected genes, compared to the results obtained from RNA-seq analysis are reported. The validation was performed on the same RNA used for RNA-seq, and the results are representative of four independent experiments. These genes were differentially expressed 2 h after exposure after CW or PW signals, and results obtained with the exposed cells were compared to the corresponding sham cells (exposed 2 h vs. sham 2 h; t-test). The table includes type of signal, gene name, fold change (FC), direction of change as up-regulation (↑), down-regulation (↓) or no changes (-) and p-value. Not significant (NS).
| 2.45 GHz | Gene | RNA-seq | RT-PCR | ||||
|---|---|---|---|---|---|---|---|
| FC | Regulation | FC | Regulation | ||||
| CW | RMRP | 8.8 | ↓ | ≤0.05 | 0.73 | ↓ | NS |
| ALMS1 | 2.06 | ↑ | ≤0.05 | 1.14 | ↑ | NS | |
| BSN | 2.37 | ↑ | ≤0.05 | 1.52 | ↑ | ≤0.001 | |
| SYNE2 | 2.06 | ↑ | ≤0.05 | 2.1 | ↑ | NS | |
| AHNAK2 | 2.18 | ↑ | ≤0.05 | 1.0 | - | NS | |
| PW | RMRP | 5.7 | ↓ | ≤0.05 | 0.96 | ↓ | NS |
| AHNAK2 | 1.5 | ↓ | ≤0.05 | 1.99 | ↑ | NS | |
Figure 6Picture of the WPC with the four Petri dishes inside. (a) WPC placed into the shielding cage with the lateral walls covered with absorbing panels. (b) Shielding cage inside the incubator with the two fans used to induce a forced air flow for temperature control.
Figure 7Temperature increase as a function of time. Measurement inside the biological sample during 2 h exposure to a CW at 2.45 GHz and 0.7 W/kg of SAR.
Candidate transcripts selected for the validation by qRT-PCR. Inventoried primer probe designs were used.
| Gene Name | Description | Assay ID |
|---|---|---|
| RMRP | RNA Component of Mitochondrial RNA Processing Endoribonuclease | Hs03298751_s1 |
| ALMS1 | Cytoskeletal protein binding | Hs00367316_m1 |
| BSN | Scaffolding protein involved in organizing the presynaptic cytoskeleton | Hs01109152_m1 |
| SYNE2 | Actin binding | Hs00794881_m1 |
| AHNAK2 | RNA binding | Hs00292832_m1 |